Search Results - "VALERY, Patricia C."
-
1
International trends in hepatocellular carcinoma incidence, 1978–2012
Published in International journal of cancer (15-07-2020)“…Primary liver cancer, the major histology of which is hepatocellular carcinoma (HCC), is the second leading cause of cancer death worldwide. We comprehensively…”
Get full text
Journal Article -
2
International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007
Published in International journal of cancer (01-10-2016)“…Primary liver cancer, the most common histologic types of which are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is the second…”
Get full text
Journal Article -
3
Projections of primary liver cancer to 2030 in 30 countries worldwide
Published in Hepatology (Baltimore, Md.) (01-02-2018)“…Primary liver cancer (PLC) is the sixth most common cancer worldwide and the second most common cause of cancer death. Future predictions can inform health…”
Get full text
Journal Article -
4
Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis
Published in Internal medicine journal (01-02-2018)“…Background Non‐alcoholic fatty liver disease (NAFLD) is a common cause of incidental liver test abnormalities. General practitioners (GP) have a key role in…”
Get full text
Journal Article -
5
A discrete choice experiment to elicit preferences for a liver screening programme in Queensland, Australia: a mixed methods study to select attributes and levels
Published in BMC health services research (05-09-2023)“…Abstract Background In Australia, the overall prevalence of liver disease is increasing. Maximising uptake of community screening programmes by understanding…”
Get full text
Journal Article -
6
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
Published in Annals of hepatology (01-11-2023)“…Among people with type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD) is very common and has an increased risk of clinically significant liver…”
Get full text
Journal Article -
7
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
Published in BMC health services research (12-04-2022)“…Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic that affects approximately half of all people with type 2 diabetes. Those with type 2…”
Get full text
Journal Article -
8
Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis
Published in Cancer epidemiology (01-04-2017)“…Highlights • The design, measures and quality of included studies varied substantially. • Low risk of bias studies found less cancer screening among women with…”
Get full text
Journal Article -
9
High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
Published in International journal for equity in health (30-04-2024)“…Liver disease is an important contributor to the mortality gap between First Nations Peoples and non-Indigenous Australian adults. Despite a high burden of…”
Get full text
Journal Article -
10
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial
Published in The lancet respiratory medicine (01-10-2013)“…Summary Background Indigenous children in high-income countries have a heavy burden of bronchiectasis unrelated to cystic fibrosis. We aimed to establish…”
Get full text
Journal Article -
11
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study
Published in BMC gastroenterology (14-07-2022)“…Abstract Background Optimal management of cirrhosis is complex, and patients often lack knowledge and skills, which can affect self-management. We assessed…”
Get full text
Journal Article -
12
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)
Published in BMC health services research (21-04-2020)“…Non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in Australia and its recent increase mirrors the obesity and type 2…”
Get full text
Journal Article -
13
Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM
Published in BMJ open gastroenterology (10-02-2021)“…ObjectiveThe prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) cirrhosis is often underestimated in healthcare…”
Get full text
Journal Article -
14
Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
Published in World journal of gastroenterology : WJG (28-10-2017)“…AIM To investigate the impact of medication beliefs, illness perceptions and quality of life on medication adherence in people with decompensated…”
Get full text
Journal Article -
15
Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
Published in PloS one (08-05-2018)“…Little is known about the impact of comorbidity on cervical cancer survival in Australian women, including whether Indigenous women's higher prevalence of…”
Get full text
Journal Article -
16
Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
Published in Hepatology communications (01-04-2022)“…It remains unclear whether screening for advanced fibrosis in the community can identify the subgroup of people with nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Journal Article -
17
Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians
Published in International journal for equity in health (17-02-2020)“…Indigenous Australians experience greater health disadvantage and have a higher prevalence of many chronic health conditions. Liver diseases leading to…”
Get full text
Journal Article -
18
Aboriginal and Torres Strait Islander patients' cancer care pathways in Queensland: Insights from health professionals
Published in Health promotion journal of Australia (01-07-2022)“…Objective: To identify points for improvements within the health system where Aboriginal and Torres Strait Islander cancer patients may experience a lack of…”
Get full text
Journal Article -
19
International variations in childhood cancer in indigenous populations: a systematic review
Published in The lancet oncology (01-02-2014)“…Summary Although the cancer burden in indigenous children has been reported in some countries, up to now, no international comparison has been made. We…”
Get full text
Journal Article -
20
Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer
Published in JGH open (01-07-2024)“…Background and Aim Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with an increased risk of extrahepatic morbidity. We compared…”
Get full text
Journal Article